Learn About Glycogen Storage Disease Type 3

What is the definition of Glycogen Storage Disease Type 3?
Glycogen storage disease type 3 (GSDIII) is an inherited disorder caused by the buildup of glycogen in the body's cells. This buildup impairs the function of certain organs and tissues, especially the liver and muscles. Symptoms typically begin in infancy and may include hypoglycemia, hyperlipidemia (excess of fats in the blood), and elevated blood levels of liver enzymes; later symptoms may include hepatomegal and chronic liver disease (cirrhosis). Some individuals have short stature and noncancerous (benign) tumors called adenomas in the liver. GSDIII is cause by genetic changes in the AGL gene and is inherited in an autosomal recessive manner. GSDIII is divided into types IIIa, IIIb, IIIc, and IIId. Types IIIa and IIIc mainly affect the liver and muscles, and GSD types IIIb and IIId typically affect only the liver.
Save information for later
Sign Up
What are the alternative names for Glycogen Storage Disease Type 3?
  • Glycogen storage disease type 3
  • Amylo-1,6-glucosidase deficiency
  • Cori disease
  • Forbes disease
  • Glycogen debrancher deficiency
  • Limit dextrinosis
Who are the top Glycogen Storage Disease Type 3 Local Doctors?
MO
Minoru Okubo
Distinguished
Highly rated in
6
conditions

National Center Of Neurology And Psychiatry

Medical Genome Center 
Tokyo, JP 

Minoru Okubo is in Tokyo, Japan. Okubo is rated as a Distinguished expert by MediFind in the treatment of Glycogen Storage Disease Type 3. He is also highly rated in 6 other conditions, according to our data. His top areas of expertise are Glycogen Storage Disease Type 3, Hyperlipidemia Type 3, Pompe Disease, and Familial Lipoprotein Lipase Deficiency.

View Profile
PL
Pascal Laforet
Distinguished
Highly rated in
51
conditions

Hôpital Raymond Poincaré

Aphp, Raymond Poincaré Hospital 
Paris, FR 

Pascal Laforet is in Paris, France. Laforet is rated as a Distinguished expert by MediFind in the treatment of Glycogen Storage Disease Type 3. He is also highly rated in 51 other conditions, according to our data. His top areas of expertise are Pompe Disease, Glycogen Storage Disease Type 3, Rhabdomyolysis, and Glutaric Acidemia Type 2.

View Profile
 
 
 
 
Learn about our expert tiers
Learn more
PL
Philippe Labrune
Distinguished
Highly rated in
10
conditions

Hôpital Antoine Béclère

Clamart, FR 92140

Philippe Labrune is in Clamart, France. Labrune is rated as a Distinguished expert by MediFind in the treatment of Glycogen Storage Disease Type 3. He is also highly rated in 10 other conditions, according to our data. His top areas of expertise are Glycogen Storage Disease Type 3, Crigler-Najjar Syndrome, Rotor Syndrome, and Von Gierke Disease.

View Profile
View All Doctors
What are the latest Glycogen Storage Disease Type 3 Clinical Trials?
Clinical Survey Study to Assess Physical Function and the Incidence of Hypoglycemia in Patients 1 Year of Age and Over With GSD III
Status: Recruiting
Start Date: May 20, 2022
Intervention Type: Other
View Trial
Summary: The primary objective of this study is to evaluate the incidence of hypoglycemia in adult and pediatric participants with glycogen storage disease type III (GSD III).
Match to trials
Find the right clinical trials for you in under a minute
Get started
Clinical Survey Study to Evaluate Biomarkers and Clinical Manifestations in Individuals With Glycogen Storage Disease Type III (GSD III)
Status: Active, not recruiting
Start Date: November 23, 2020
Intervention Type: Other
View Trial
Summary: The primary objective of this study is to evaluate potential biomarkers of GSD III.
View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center

What are the Latest Advances for Glycogen Storage Disease Type 3?

There is no recent research available for this condition. Please check back because thousands of new papers are published every week and we strive to find and display the most recent relevant research as soon as it is available.